IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
about
IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous systemRhinovirus and childhood asthma: an updateInsights into Group 2 Innate Lymphoid Cells in Human Airway DiseaseRecent advances in understanding and managing asthmaRespiratory viral infections and host responses; insights from genomicsAllergen-encoded signals that control allergic responsesRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Rhinovirus infection results in stronger and more persistent genomic dysregulation: Evidence for altered innate immune response in asthmatics at baseline, early in infection, and during convalescencePathogenic CD4+ T cells in patients with asthma.Immune Responses in Rhinovirus-Induced Asthma Exacerbations.Novel Analysis of Immune Cells from Nasal Microbiopsy Demonstrates Reliable, Reproducible Data for Immune Populations, and Superior Cytokine Detection Compared to Nasal Wash.Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis.A Comprehensive Evaluation of Nasal and Bronchial Cytokines and Chemokines Following Experimental Rhinovirus Infection in Allergic Asthma: Increased Interferons (IFN-γ and IFN-λ) and Type 2 Inflammation (IL-5 and IL-13)Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation.Rhinovirus and asthma: a storied history of incompatibility.IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk.The Induction of IL-33 in the Sinus Epithelium and Its Influence on T-Helper Cell Responses.Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms.Rhinoviral stimuli, epithelial factors and ATP signalling contribute to bronchial smooth muscle production of IL-33Barrier function of the nasal mucosa in health and type-2 biased airway diseases.Current and future biomarkers in allergic asthma.Interferon regulatory factor 7 regulates airway epithelial cell responses to human rhinovirus infection.The sticky relationship between allergies and infections.Increased expression of upstream TH2-cytokines in a mouse model of viral-induced asthma exacerbation.Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation PathwayTbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection.Rhinovirus wheezing illness in infancy is associated with medically attended third year wheezing in low risk infants: results of a healthy birth cohort study.Innate lymphoid cells in asthma: Will they take your breath away?Current concepts of severe asthmaIFN Deficiency in Asthma Attacks. Is Restoring Toll-like Receptor-7 Expression a New Treatment Approach in Severe Asthma?Alternative splicing of interleukin-33 and type 2 inflammation in asthma.Potential of IL-33 for Preventing the Kidney Injury via Regulating the Lipid Metabolism in Gout Patients.Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.Allergen-Specific CD4(+) T Cells in Human Asthma.Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.Lipopolysaccharide Attenuates Induction of Proallergic Cytokines, Thymic Stromal Lymphopoietin, and Interleukin 33 in Respiratory Epithelial Cells Stimulated with PolyI:C and Human Parechovirus.Interactions of Respiratory Viruses and the Nasal Microbiota during the First Year of Life in Healthy Infants.The potential role of IL-33/ST2 signaling in fibrotic diseases.The need to differentiate between adults and children when treating severe asthma.Update in Asthma 2014.
P2860
Q26700067-2330479C-EE5F-4781-9847-9B3470068B28Q28067908-097FCDAA-0BB9-45A0-9299-4CADA65C6D97Q28076134-99CA64F8-74C8-4325-8333-0170BC1D8281Q28077915-5DF5577F-01FE-4851-9DCF-0DE5954E603CQ28079922-2F4DD0B3-17A9-4381-9831-EE1FA7F6E899Q28080818-011A896F-A8D4-43F1-B7D0-304592E10F32Q30240274-39C2A591-52D0-4D9F-9325-245D9D581A4AQ30252319-6D42F8BF-A289-41DE-82DA-27B397E6F061Q30252507-B47E92B7-7ECC-4A41-ACFB-1D923AC4DF69Q30275562-06182B26-A0FE-47FA-98E0-C257A1D6B4F1Q31155618-947A575A-6AC6-4E60-8846-FEE66CDDA97BQ33644174-DA22F27B-0DF6-4315-8935-E4D13E1C1845Q33715731-8FBB1275-521B-4560-86CA-55010044AB39Q34493943-12DB6900-C6E9-4165-BCBF-E55B38C140B3Q35082562-AE7F4E41-D4D7-477C-9632-ACD5C09791A7Q35565295-3B962CB4-B8B9-4BDE-A28E-49AFB19A1512Q35620005-26BFEF67-A4A1-4551-A3A3-77519F4A71A5Q35681568-536DD358-3AA0-4F78-A136-8D4BD8A5DE87Q35759343-0B5F7053-2B3E-41D6-AE7F-9599F0786027Q35852413-A355EDE9-E2CA-48C1-9C3E-8FD1A92D6DE7Q35878914-84B6D481-66DF-4D26-82C4-47EB74738834Q35904436-F6B91FBA-79C7-4459-AAC7-F07CFC9AD24FQ35905733-C561B13C-E204-4395-B053-B94B54D1D74EQ35924449-0E3C9BB3-0F97-482B-ADEF-32158541B98DQ36119388-2A8C6F21-6632-45F8-8F96-65FD533BEEE2Q36147533-6DF43770-EE29-4ABA-A01E-522AE9056CD9Q36410595-28856BB9-7F00-473D-893C-7E9B9CFACC34Q36973089-67BEB514-BE3F-412C-87A0-0854B0909FD4Q37042266-046A64C0-0F38-488E-A7FA-795A576AEC58Q37125528-B282656F-66E1-4473-A84C-F9DF30EF6456Q37161547-CB6C7314-B6E7-4397-BBED-6970938638ADQ37192446-E76D1A1C-3DA9-4328-B536-932EE45147CDQ37239031-14F0CCF0-D662-40DD-BFA0-2E5F9FDF0C12Q37241577-E12378B2-20DA-4CE0-9B65-6BC03BBACD3CQ37273929-C39DAADB-680F-44D8-B941-D31393D0EAEAQ37363183-BB2FB5E1-586F-4032-9B6C-34F99B997E9DQ37430600-D2875C8F-0465-44D1-BA89-E385656D4D3AQ38424483-B1F703FB-2241-475E-A638-DCCCBAF93ABEQ38547303-F81702EE-0716-4B3A-894E-D37D49007EE6Q38547604-2F4982E7-8DA9-41D6-909D-4A36D006AA3A
P2860
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@ast
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@en
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@nl
type
label
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@ast
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@en
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@nl
prefLabel
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@ast
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@en
IL-33-dependent type 2 inflamm ...... asthma exacerbations in vivo.
@nl
P2093
P2860
P50
P1476
IL-33-dependent type 2 inflamm ...... d asthma exacerbations in vivo
@en
P2093
Alexandra Nikonova
Aurica G Telcian
Batika M J Rana
Betty W H Shamji
David J Jackson
Duncan Hunt
Eteri Bakhsoliani
Heidi Makrinioti
Jaideep Dhariwal
James Porter
P2860
P304
P356
10.1164/RCCM.201406-1039OC
P407
P50
P577
2014-12-01T00:00:00Z